Global Infectious Disease POC Diagnostic Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Infectious Disease POC Diagnostic market size is predicted to grow from US$ 1766 million in 2025 to US$ 3247 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.
Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC testing enables faster diagnosis of infectious disease near the patient site providing quick results? Severalresearchers are now focused on the development of multiplex point-of-care diagnostic technologies. These MPOCTdevices consist of hybridization papers, array settings, bead technology, or microftuidic systems that reduce the assaysteps and provide diagnosis results in 15-30 minutes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Infectious Disease POC Diagnostic Industry Forecast” looks at past sales and reviews total world Infectious Disease POC Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease POC Diagnostic sales for 2025 through 2031. With Infectious Disease POC Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease POC Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Infectious Disease POC Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease POC Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease POC Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease POC Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease POC Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease POC Diagnostic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Infectious Disease POC Diagnostic market?
What factors are driving Infectious Disease POC Diagnostic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infectious Disease POC Diagnostic market opportunities vary by end market size?
How does Infectious Disease POC Diagnostic break out by Type, by Application?
The global Infectious Disease POC Diagnostic market size is predicted to grow from US$ 1766 million in 2025 to US$ 3247 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.
Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC testing enables faster diagnosis of infectious disease near the patient site providing quick results? Severalresearchers are now focused on the development of multiplex point-of-care diagnostic technologies. These MPOCTdevices consist of hybridization papers, array settings, bead technology, or microftuidic systems that reduce the assaysteps and provide diagnosis results in 15-30 minutes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Infectious Disease POC Diagnostic Industry Forecast” looks at past sales and reviews total world Infectious Disease POC Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease POC Diagnostic sales for 2025 through 2031. With Infectious Disease POC Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease POC Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Infectious Disease POC Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease POC Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease POC Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease POC Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease POC Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease POC Diagnostic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lateral Flow Immunoassay
- Agglutination Test
- Flow-Through Test
- Molecular Diagnostics
- Others
- Hospital Bedside
- Urgent Care and Retail Clinics
- Home and Self-Testing
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
- Abbott Laboratories
- Quest Diagnostics
- BD
- bioMйrieux
- Cardinal Health
- Cepheid
- Trinity Biotech
- Quidel Corporation
- Bio-Rad Laboratories
What is the 10-year outlook for the global Infectious Disease POC Diagnostic market?
What factors are driving Infectious Disease POC Diagnostic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infectious Disease POC Diagnostic market opportunities vary by end market size?
How does Infectious Disease POC Diagnostic break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease POC Diagnostic Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Infectious Disease POC Diagnostic by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Infectious Disease POC Diagnostic by Country/Region, 2020, 2024 & 2031
2.2 Infectious Disease POC Diagnostic Segment by Type
2.2.1 Lateral Flow Immunoassay
2.2.2 Agglutination Test
2.2.3 Flow-Through Test
2.2.4 Molecular Diagnostics
2.2.5 Others
2.3 Infectious Disease POC Diagnostic Sales by Type
2.3.1 Global Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
2.3.2 Global Infectious Disease POC Diagnostic Revenue and Market Share by Type (2020-2025)
2.3.3 Global Infectious Disease POC Diagnostic Sale Price by Type (2020-2025)
2.4 Infectious Disease POC Diagnostic Segment by Application
2.4.1 Hospital Bedside
2.4.2 Urgent Care and Retail Clinics
2.4.3 Home and Self-Testing
2.4.4 Others
2.5 Infectious Disease POC Diagnostic Sales by Application
2.5.1 Global Infectious Disease POC Diagnostic Sale Market Share by Application (2020-2025)
2.5.2 Global Infectious Disease POC Diagnostic Revenue and Market Share by Application (2020-2025)
2.5.3 Global Infectious Disease POC Diagnostic Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Infectious Disease POC Diagnostic Breakdown Data by Company
3.1.1 Global Infectious Disease POC Diagnostic Annual Sales by Company (2020-2025)
3.1.2 Global Infectious Disease POC Diagnostic Sales Market Share by Company (2020-2025)
3.2 Global Infectious Disease POC Diagnostic Annual Revenue by Company (2020-2025)
3.2.1 Global Infectious Disease POC Diagnostic Revenue by Company (2020-2025)
3.2.2 Global Infectious Disease POC Diagnostic Revenue Market Share by Company (2020-2025)
3.3 Global Infectious Disease POC Diagnostic Sale Price by Company
3.4 Key Manufacturers Infectious Disease POC Diagnostic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Disease POC Diagnostic Product Location Distribution
3.4.2 Players Infectious Disease POC Diagnostic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFECTIOUS DISEASE POC DIAGNOSTIC BY GEOGRAPHIC REGION
4.1 World Historic Infectious Disease POC Diagnostic Market Size by Geographic Region (2020-2025)
4.1.1 Global Infectious Disease POC Diagnostic Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Infectious Disease POC Diagnostic Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Infectious Disease POC Diagnostic Market Size by Country/Region (2020-2025)
4.2.1 Global Infectious Disease POC Diagnostic Annual Sales by Country/Region (2020-2025)
4.2.2 Global Infectious Disease POC Diagnostic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Disease POC Diagnostic Sales Growth
4.4 APAC Infectious Disease POC Diagnostic Sales Growth
4.5 Europe Infectious Disease POC Diagnostic Sales Growth
4.6 Middle East & Africa Infectious Disease POC Diagnostic Sales Growth
5 AMERICAS
5.1 Americas Infectious Disease POC Diagnostic Sales by Country
5.1.1 Americas Infectious Disease POC Diagnostic Sales by Country (2020-2025)
5.1.2 Americas Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
5.2 Americas Infectious Disease POC Diagnostic Sales by Type (2020-2025)
5.3 Americas Infectious Disease POC Diagnostic Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease POC Diagnostic Sales by Region
6.1.1 APAC Infectious Disease POC Diagnostic Sales by Region (2020-2025)
6.1.2 APAC Infectious Disease POC Diagnostic Revenue by Region (2020-2025)
6.2 APAC Infectious Disease POC Diagnostic Sales by Type (2020-2025)
6.3 APAC Infectious Disease POC Diagnostic Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infectious Disease POC Diagnostic by Country
7.1.1 Europe Infectious Disease POC Diagnostic Sales by Country (2020-2025)
7.1.2 Europe Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
7.2 Europe Infectious Disease POC Diagnostic Sales by Type (2020-2025)
7.3 Europe Infectious Disease POC Diagnostic Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease POC Diagnostic by Country
8.1.1 Middle East & Africa Infectious Disease POC Diagnostic Sales by Country (2020-2025)
8.1.2 Middle East & Africa Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
8.2 Middle East & Africa Infectious Disease POC Diagnostic Sales by Type (2020-2025)
8.3 Middle East & Africa Infectious Disease POC Diagnostic Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infectious Disease POC Diagnostic
10.3 Manufacturing Process Analysis of Infectious Disease POC Diagnostic
10.4 Industry Chain Structure of Infectious Disease POC Diagnostic
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infectious Disease POC Diagnostic Distributors
11.3 Infectious Disease POC Diagnostic Customer
12 WORLD FORECAST REVIEW FOR INFECTIOUS DISEASE POC DIAGNOSTIC BY GEOGRAPHIC REGION
12.1 Global Infectious Disease POC Diagnostic Market Size Forecast by Region
12.1.1 Global Infectious Disease POC Diagnostic Forecast by Region (2026-2031)
12.1.2 Global Infectious Disease POC Diagnostic Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Infectious Disease POC Diagnostic Forecast by Type (2026-2031)
12.7 Global Infectious Disease POC Diagnostic Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Information
13.1.2 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 F. Hoffmann-La Roche Main Business Overview
13.1.5 F. Hoffmann-La Roche Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.3.3 Abbott Laboratories Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Quest Diagnostics
13.4.1 Quest Diagnostics Company Information
13.4.2 Quest Diagnostics Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.4.3 Quest Diagnostics Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Quest Diagnostics Main Business Overview
13.4.5 Quest Diagnostics Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.5.3 BD Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 bioMйrieux
13.6.1 bioMйrieux Company Information
13.6.2 bioMйrieux Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.6.3 bioMйrieux Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 bioMйrieux Main Business Overview
13.6.5 bioMйrieux Latest Developments
13.7 Cardinal Health
13.7.1 Cardinal Health Company Information
13.7.2 Cardinal Health Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.7.3 Cardinal Health Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cardinal Health Main Business Overview
13.7.5 Cardinal Health Latest Developments
13.8 Cepheid
13.8.1 Cepheid Company Information
13.8.2 Cepheid Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.8.3 Cepheid Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Cepheid Main Business Overview
13.8.5 Cepheid Latest Developments
13.9 Trinity Biotech
13.9.1 Trinity Biotech Company Information
13.9.2 Trinity Biotech Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.9.3 Trinity Biotech Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Trinity Biotech Main Business Overview
13.9.5 Trinity Biotech Latest Developments
13.10 Quidel Corporation
13.10.1 Quidel Corporation Company Information
13.10.2 Quidel Corporation Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.10.3 Quidel Corporation Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Quidel Corporation Main Business Overview
13.10.5 Quidel Corporation Latest Developments
13.11 Bio-Rad Laboratories
13.11.1 Bio-Rad Laboratories Company Information
13.11.2 Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.11.3 Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bio-Rad Laboratories Main Business Overview
13.11.5 Bio-Rad Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease POC Diagnostic Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Infectious Disease POC Diagnostic by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Infectious Disease POC Diagnostic by Country/Region, 2020, 2024 & 2031
2.2 Infectious Disease POC Diagnostic Segment by Type
2.2.1 Lateral Flow Immunoassay
2.2.2 Agglutination Test
2.2.3 Flow-Through Test
2.2.4 Molecular Diagnostics
2.2.5 Others
2.3 Infectious Disease POC Diagnostic Sales by Type
2.3.1 Global Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
2.3.2 Global Infectious Disease POC Diagnostic Revenue and Market Share by Type (2020-2025)
2.3.3 Global Infectious Disease POC Diagnostic Sale Price by Type (2020-2025)
2.4 Infectious Disease POC Diagnostic Segment by Application
2.4.1 Hospital Bedside
2.4.2 Urgent Care and Retail Clinics
2.4.3 Home and Self-Testing
2.4.4 Others
2.5 Infectious Disease POC Diagnostic Sales by Application
2.5.1 Global Infectious Disease POC Diagnostic Sale Market Share by Application (2020-2025)
2.5.2 Global Infectious Disease POC Diagnostic Revenue and Market Share by Application (2020-2025)
2.5.3 Global Infectious Disease POC Diagnostic Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Infectious Disease POC Diagnostic Breakdown Data by Company
3.1.1 Global Infectious Disease POC Diagnostic Annual Sales by Company (2020-2025)
3.1.2 Global Infectious Disease POC Diagnostic Sales Market Share by Company (2020-2025)
3.2 Global Infectious Disease POC Diagnostic Annual Revenue by Company (2020-2025)
3.2.1 Global Infectious Disease POC Diagnostic Revenue by Company (2020-2025)
3.2.2 Global Infectious Disease POC Diagnostic Revenue Market Share by Company (2020-2025)
3.3 Global Infectious Disease POC Diagnostic Sale Price by Company
3.4 Key Manufacturers Infectious Disease POC Diagnostic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Disease POC Diagnostic Product Location Distribution
3.4.2 Players Infectious Disease POC Diagnostic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFECTIOUS DISEASE POC DIAGNOSTIC BY GEOGRAPHIC REGION
4.1 World Historic Infectious Disease POC Diagnostic Market Size by Geographic Region (2020-2025)
4.1.1 Global Infectious Disease POC Diagnostic Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Infectious Disease POC Diagnostic Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Infectious Disease POC Diagnostic Market Size by Country/Region (2020-2025)
4.2.1 Global Infectious Disease POC Diagnostic Annual Sales by Country/Region (2020-2025)
4.2.2 Global Infectious Disease POC Diagnostic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Disease POC Diagnostic Sales Growth
4.4 APAC Infectious Disease POC Diagnostic Sales Growth
4.5 Europe Infectious Disease POC Diagnostic Sales Growth
4.6 Middle East & Africa Infectious Disease POC Diagnostic Sales Growth
5 AMERICAS
5.1 Americas Infectious Disease POC Diagnostic Sales by Country
5.1.1 Americas Infectious Disease POC Diagnostic Sales by Country (2020-2025)
5.1.2 Americas Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
5.2 Americas Infectious Disease POC Diagnostic Sales by Type (2020-2025)
5.3 Americas Infectious Disease POC Diagnostic Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease POC Diagnostic Sales by Region
6.1.1 APAC Infectious Disease POC Diagnostic Sales by Region (2020-2025)
6.1.2 APAC Infectious Disease POC Diagnostic Revenue by Region (2020-2025)
6.2 APAC Infectious Disease POC Diagnostic Sales by Type (2020-2025)
6.3 APAC Infectious Disease POC Diagnostic Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infectious Disease POC Diagnostic by Country
7.1.1 Europe Infectious Disease POC Diagnostic Sales by Country (2020-2025)
7.1.2 Europe Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
7.2 Europe Infectious Disease POC Diagnostic Sales by Type (2020-2025)
7.3 Europe Infectious Disease POC Diagnostic Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease POC Diagnostic by Country
8.1.1 Middle East & Africa Infectious Disease POC Diagnostic Sales by Country (2020-2025)
8.1.2 Middle East & Africa Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
8.2 Middle East & Africa Infectious Disease POC Diagnostic Sales by Type (2020-2025)
8.3 Middle East & Africa Infectious Disease POC Diagnostic Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infectious Disease POC Diagnostic
10.3 Manufacturing Process Analysis of Infectious Disease POC Diagnostic
10.4 Industry Chain Structure of Infectious Disease POC Diagnostic
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infectious Disease POC Diagnostic Distributors
11.3 Infectious Disease POC Diagnostic Customer
12 WORLD FORECAST REVIEW FOR INFECTIOUS DISEASE POC DIAGNOSTIC BY GEOGRAPHIC REGION
12.1 Global Infectious Disease POC Diagnostic Market Size Forecast by Region
12.1.1 Global Infectious Disease POC Diagnostic Forecast by Region (2026-2031)
12.1.2 Global Infectious Disease POC Diagnostic Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Infectious Disease POC Diagnostic Forecast by Type (2026-2031)
12.7 Global Infectious Disease POC Diagnostic Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Information
13.1.2 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 F. Hoffmann-La Roche Main Business Overview
13.1.5 F. Hoffmann-La Roche Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.3.3 Abbott Laboratories Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Quest Diagnostics
13.4.1 Quest Diagnostics Company Information
13.4.2 Quest Diagnostics Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.4.3 Quest Diagnostics Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Quest Diagnostics Main Business Overview
13.4.5 Quest Diagnostics Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.5.3 BD Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 bioMйrieux
13.6.1 bioMйrieux Company Information
13.6.2 bioMйrieux Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.6.3 bioMйrieux Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 bioMйrieux Main Business Overview
13.6.5 bioMйrieux Latest Developments
13.7 Cardinal Health
13.7.1 Cardinal Health Company Information
13.7.2 Cardinal Health Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.7.3 Cardinal Health Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cardinal Health Main Business Overview
13.7.5 Cardinal Health Latest Developments
13.8 Cepheid
13.8.1 Cepheid Company Information
13.8.2 Cepheid Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.8.3 Cepheid Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Cepheid Main Business Overview
13.8.5 Cepheid Latest Developments
13.9 Trinity Biotech
13.9.1 Trinity Biotech Company Information
13.9.2 Trinity Biotech Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.9.3 Trinity Biotech Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Trinity Biotech Main Business Overview
13.9.5 Trinity Biotech Latest Developments
13.10 Quidel Corporation
13.10.1 Quidel Corporation Company Information
13.10.2 Quidel Corporation Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.10.3 Quidel Corporation Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Quidel Corporation Main Business Overview
13.10.5 Quidel Corporation Latest Developments
13.11 Bio-Rad Laboratories
13.11.1 Bio-Rad Laboratories Company Information
13.11.2 Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.11.3 Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bio-Rad Laboratories Main Business Overview
13.11.5 Bio-Rad Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Disease POC Diagnostic Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Infectious Disease POC Diagnostic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lateral Flow Immunoassay
Table 4. Major Players of Agglutination Test
Table 5. Major Players of Flow-Through Test
Table 6. Major Players of Molecular Diagnostics
Table 7. Major Players of Others
Table 8. Global Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 9. Global Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Table 10. Global Infectious Disease POC Diagnostic Revenue by Type (2020-2025) & ($ million)
Table 11. Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2020-2025)
Table 12. Global Infectious Disease POC Diagnostic Sale Price by Type (2020-2025) & (US$/Unit)
Table 13. Global Infectious Disease POC Diagnostic Sale by Application (2020-2025) & (K Units)
Table 14. Global Infectious Disease POC Diagnostic Sale Market Share by Application (2020-2025)
Table 15. Global Infectious Disease POC Diagnostic Revenue by Application (2020-2025) & ($ million)
Table 16. Global Infectious Disease POC Diagnostic Revenue Market Share by Application (2020-2025)
Table 17. Global Infectious Disease POC Diagnostic Sale Price by Application (2020-2025) & (US$/Unit)
Table 18. Global Infectious Disease POC Diagnostic Sales by Company (2020-2025) & (K Units)
Table 19. Global Infectious Disease POC Diagnostic Sales Market Share by Company (2020-2025)
Table 20. Global Infectious Disease POC Diagnostic Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Infectious Disease POC Diagnostic Revenue Market Share by Company (2020-2025)
Table 22. Global Infectious Disease POC Diagnostic Sale Price by Company (2020-2025) & (US$/Unit)
Table 23. Key Manufacturers Infectious Disease POC Diagnostic Producing Area Distribution and Sales Area
Table 24. Players Infectious Disease POC Diagnostic Products Offered
Table 25. Infectious Disease POC Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Infectious Disease POC Diagnostic Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Infectious Disease POC Diagnostic Sales Market Share Geographic Region (2020-2025)
Table 30. Global Infectious Disease POC Diagnostic Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Infectious Disease POC Diagnostic Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Infectious Disease POC Diagnostic Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Infectious Disease POC Diagnostic Sales Market Share by Country/Region (2020-2025)
Table 34. Global Infectious Disease POC Diagnostic Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Infectious Disease POC Diagnostic Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)
Table 37. Americas Infectious Disease POC Diagnostic Sales Market Share by Country (2020-2025)
Table 38. Americas Infectious Disease POC Diagnostic Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 40. Americas Infectious Disease POC Diagnostic Sales by Application (2020-2025) & (K Units)
Table 41. APAC Infectious Disease POC Diagnostic Sales by Region (2020-2025) & (K Units)
Table 42. APAC Infectious Disease POC Diagnostic Sales Market Share by Region (2020-2025)
Table 43. APAC Infectious Disease POC Diagnostic Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 45. APAC Infectious Disease POC Diagnostic Sales by Application (2020-2025) & (K Units)
Table 46. Europe Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease POC Diagnostic Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 49. Europe Infectious Disease POC Diagnostic Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Infectious Disease POC Diagnostic Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Infectious Disease POC Diagnostic
Table 55. Key Market Challenges & Risks of Infectious Disease POC Diagnostic
Table 56. Key Industry Trends of Infectious Disease POC Diagnostic
Table 57. Infectious Disease POC Diagnostic Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Infectious Disease POC Diagnostic Distributors List
Table 60. Infectious Disease POC Diagnostic Customer List
Table 61. Global Infectious Disease POC Diagnostic Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Infectious Disease POC Diagnostic Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Infectious Disease POC Diagnostic Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Infectious Disease POC Diagnostic Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Infectious Disease POC Diagnostic Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Infectious Disease POC Diagnostic Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Infectious Disease POC Diagnostic Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Infectious Disease POC Diagnostic Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Infectious Disease POC Diagnostic Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Infectious Disease POC Diagnostic Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Infectious Disease POC Diagnostic Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Infectious Disease POC Diagnostic Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Infectious Disease POC Diagnostic Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Infectious Disease POC Diagnostic Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. F. Hoffmann-La Roche Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 76. F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 77. F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. F. Hoffmann-La Roche Main Business
Table 79. F. Hoffmann-La Roche Latest Developments
Table 80. Thermo Fisher Scientific Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 81. Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 82. Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Main Business
Table 84. Thermo Fisher Scientific Latest Developments
Table 85. Abbott Laboratories Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 87. Abbott Laboratories Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Main Business
Table 89. Abbott Laboratories Latest Developments
Table 90. Quest Diagnostics Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 91. Quest Diagnostics Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 92. Quest Diagnostics Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Quest Diagnostics Main Business
Table 94. Quest Diagnostics Latest Developments
Table 95. BD Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 96. BD Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 97. BD Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD Main Business
Table 99. BD Latest Developments
Table 100. bioMйrieux Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 101. bioMйrieux Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 102. bioMйrieux Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. bioMйrieux Main Business
Table 104. bioMйrieux Latest Developments
Table 105. Cardinal Health Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 106. Cardinal Health Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 107. Cardinal Health Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cardinal Health Main Business
Table 109. Cardinal Health Latest Developments
Table 110. Cepheid Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 111. Cepheid Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 112. Cepheid Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cepheid Main Business
Table 114. Cepheid Latest Developments
Table 115. Trinity Biotech Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 116. Trinity Biotech Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 117. Trinity Biotech Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Trinity Biotech Main Business
Table 119. Trinity Biotech Latest Developments
Table 120. Quidel Corporation Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 121. Quidel Corporation Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 122. Quidel Corporation Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Quidel Corporation Main Business
Table 124. Quidel Corporation Latest Developments
Table 125. Bio-Rad Laboratories Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 126. Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 127. Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Bio-Rad Laboratories Main Business
Table 129. Bio-Rad Laboratories Latest Developments
Table 1. Infectious Disease POC Diagnostic Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Infectious Disease POC Diagnostic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lateral Flow Immunoassay
Table 4. Major Players of Agglutination Test
Table 5. Major Players of Flow-Through Test
Table 6. Major Players of Molecular Diagnostics
Table 7. Major Players of Others
Table 8. Global Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 9. Global Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Table 10. Global Infectious Disease POC Diagnostic Revenue by Type (2020-2025) & ($ million)
Table 11. Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2020-2025)
Table 12. Global Infectious Disease POC Diagnostic Sale Price by Type (2020-2025) & (US$/Unit)
Table 13. Global Infectious Disease POC Diagnostic Sale by Application (2020-2025) & (K Units)
Table 14. Global Infectious Disease POC Diagnostic Sale Market Share by Application (2020-2025)
Table 15. Global Infectious Disease POC Diagnostic Revenue by Application (2020-2025) & ($ million)
Table 16. Global Infectious Disease POC Diagnostic Revenue Market Share by Application (2020-2025)
Table 17. Global Infectious Disease POC Diagnostic Sale Price by Application (2020-2025) & (US$/Unit)
Table 18. Global Infectious Disease POC Diagnostic Sales by Company (2020-2025) & (K Units)
Table 19. Global Infectious Disease POC Diagnostic Sales Market Share by Company (2020-2025)
Table 20. Global Infectious Disease POC Diagnostic Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Infectious Disease POC Diagnostic Revenue Market Share by Company (2020-2025)
Table 22. Global Infectious Disease POC Diagnostic Sale Price by Company (2020-2025) & (US$/Unit)
Table 23. Key Manufacturers Infectious Disease POC Diagnostic Producing Area Distribution and Sales Area
Table 24. Players Infectious Disease POC Diagnostic Products Offered
Table 25. Infectious Disease POC Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Infectious Disease POC Diagnostic Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Infectious Disease POC Diagnostic Sales Market Share Geographic Region (2020-2025)
Table 30. Global Infectious Disease POC Diagnostic Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Infectious Disease POC Diagnostic Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Infectious Disease POC Diagnostic Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Infectious Disease POC Diagnostic Sales Market Share by Country/Region (2020-2025)
Table 34. Global Infectious Disease POC Diagnostic Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Infectious Disease POC Diagnostic Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)
Table 37. Americas Infectious Disease POC Diagnostic Sales Market Share by Country (2020-2025)
Table 38. Americas Infectious Disease POC Diagnostic Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 40. Americas Infectious Disease POC Diagnostic Sales by Application (2020-2025) & (K Units)
Table 41. APAC Infectious Disease POC Diagnostic Sales by Region (2020-2025) & (K Units)
Table 42. APAC Infectious Disease POC Diagnostic Sales Market Share by Region (2020-2025)
Table 43. APAC Infectious Disease POC Diagnostic Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 45. APAC Infectious Disease POC Diagnostic Sales by Application (2020-2025) & (K Units)
Table 46. Europe Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease POC Diagnostic Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 49. Europe Infectious Disease POC Diagnostic Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Infectious Disease POC Diagnostic Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Infectious Disease POC Diagnostic Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Infectious Disease POC Diagnostic
Table 55. Key Market Challenges & Risks of Infectious Disease POC Diagnostic
Table 56. Key Industry Trends of Infectious Disease POC Diagnostic
Table 57. Infectious Disease POC Diagnostic Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Infectious Disease POC Diagnostic Distributors List
Table 60. Infectious Disease POC Diagnostic Customer List
Table 61. Global Infectious Disease POC Diagnostic Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Infectious Disease POC Diagnostic Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Infectious Disease POC Diagnostic Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Infectious Disease POC Diagnostic Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Infectious Disease POC Diagnostic Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Infectious Disease POC Diagnostic Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Infectious Disease POC Diagnostic Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Infectious Disease POC Diagnostic Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Infectious Disease POC Diagnostic Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Infectious Disease POC Diagnostic Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Infectious Disease POC Diagnostic Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Infectious Disease POC Diagnostic Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Infectious Disease POC Diagnostic Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Infectious Disease POC Diagnostic Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. F. Hoffmann-La Roche Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 76. F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 77. F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. F. Hoffmann-La Roche Main Business
Table 79. F. Hoffmann-La Roche Latest Developments
Table 80. Thermo Fisher Scientific Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 81. Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 82. Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Main Business
Table 84. Thermo Fisher Scientific Latest Developments
Table 85. Abbott Laboratories Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 87. Abbott Laboratories Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Main Business
Table 89. Abbott Laboratories Latest Developments
Table 90. Quest Diagnostics Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 91. Quest Diagnostics Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 92. Quest Diagnostics Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Quest Diagnostics Main Business
Table 94. Quest Diagnostics Latest Developments
Table 95. BD Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 96. BD Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 97. BD Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD Main Business
Table 99. BD Latest Developments
Table 100. bioMйrieux Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 101. bioMйrieux Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 102. bioMйrieux Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. bioMйrieux Main Business
Table 104. bioMйrieux Latest Developments
Table 105. Cardinal Health Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 106. Cardinal Health Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 107. Cardinal Health Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cardinal Health Main Business
Table 109. Cardinal Health Latest Developments
Table 110. Cepheid Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 111. Cepheid Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 112. Cepheid Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cepheid Main Business
Table 114. Cepheid Latest Developments
Table 115. Trinity Biotech Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 116. Trinity Biotech Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 117. Trinity Biotech Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Trinity Biotech Main Business
Table 119. Trinity Biotech Latest Developments
Table 120. Quidel Corporation Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 121. Quidel Corporation Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 122. Quidel Corporation Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Quidel Corporation Main Business
Table 124. Quidel Corporation Latest Developments
Table 125. Bio-Rad Laboratories Basic Information, Infectious Disease POC Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 126. Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
Table 127. Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Bio-Rad Laboratories Main Business
Table 129. Bio-Rad Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Picture of Infectious Disease POC Diagnostic
Figure 2. Infectious Disease POC Diagnostic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infectious Disease POC Diagnostic Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Infectious Disease POC Diagnostic Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Infectious Disease POC Diagnostic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Infectious Disease POC Diagnostic Sales Market Share by Country/Region (2024)
Figure 10. Infectious Disease POC Diagnostic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lateral Flow Immunoassay
Figure 12. Product Picture of Agglutination Test
Figure 13. Product Picture of Flow-Through Test
Figure 14. Product Picture of Molecular Diagnostics
Figure 15. Product Picture of Others
Figure 16. Global Infectious Disease POC Diagnostic Sales Market Share by Type in 2025
Figure 17. Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2020-2025)
Figure 18. Infectious Disease POC Diagnostic Consumed in Hospital Bedside
Figure 19. Global Infectious Disease POC Diagnostic Market: Hospital Bedside (2020-2025) & (K Units)
Figure 20. Infectious Disease POC Diagnostic Consumed in Urgent Care and Retail Clinics
Figure 21. Global Infectious Disease POC Diagnostic Market: Urgent Care and Retail Clinics (2020-2025) & (K Units)
Figure 22. Infectious Disease POC Diagnostic Consumed in Home and Self-Testing
Figure 23. Global Infectious Disease POC Diagnostic Market: Home and Self-Testing (2020-2025) & (K Units)
Figure 24. Infectious Disease POC Diagnostic Consumed in Others
Figure 25. Global Infectious Disease POC Diagnostic Market: Others (2020-2025) & (K Units)
Figure 26. Global Infectious Disease POC Diagnostic Sale Market Share by Application (2024)
Figure 27. Global Infectious Disease POC Diagnostic Revenue Market Share by Application in 2025
Figure 28. Infectious Disease POC Diagnostic Sales by Company in 2025 (K Units)
Figure 29. Global Infectious Disease POC Diagnostic Sales Market Share by Company in 2025
Figure 30. Infectious Disease POC Diagnostic Revenue by Company in 2025 ($ millions)
Figure 31. Global Infectious Disease POC Diagnostic Revenue Market Share by Company in 2025
Figure 32. Global Infectious Disease POC Diagnostic Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Infectious Disease POC Diagnostic Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Infectious Disease POC Diagnostic Sales 2020-2025 (K Units)
Figure 35. Americas Infectious Disease POC Diagnostic Revenue 2020-2025 ($ millions)
Figure 36. APAC Infectious Disease POC Diagnostic Sales 2020-2025 (K Units)
Figure 37. APAC Infectious Disease POC Diagnostic Revenue 2020-2025 ($ millions)
Figure 38. Europe Infectious Disease POC Diagnostic Sales 2020-2025 (K Units)
Figure 39. Europe Infectious Disease POC Diagnostic Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Infectious Disease POC Diagnostic Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Infectious Disease POC Diagnostic Revenue 2020-2025 ($ millions)
Figure 42. Americas Infectious Disease POC Diagnostic Sales Market Share by Country in 2025
Figure 43. Americas Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2025)
Figure 44. Americas Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Figure 45. Americas Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)
Figure 46. United States Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Infectious Disease POC Diagnostic Sales Market Share by Region in 2025
Figure 51. APAC Infectious Disease POC Diagnostic Revenue Market Share by Region (2020-2025)
Figure 52. APAC Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Figure 53. APAC Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)
Figure 54. China Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 58. India Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Infectious Disease POC Diagnostic Sales Market Share by Country in 2025
Figure 62. Europe Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2025)
Figure 63. Europe Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Figure 64. Europe Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)
Figure 65. Germany Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 66. France Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Infectious Disease POC Diagnostic Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)
Figure 73. Egypt Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Infectious Disease POC Diagnostic in 2025
Figure 79. Manufacturing Process Analysis of Infectious Disease POC Diagnostic
Figure 80. Industry Chain Structure of Infectious Disease POC Diagnostic
Figure 81. Channels of Distribution
Figure 82. Global Infectious Disease POC Diagnostic Sales Market Forecast by Region (2026-2031)
Figure 83. Global Infectious Disease POC Diagnostic Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Infectious Disease POC Diagnostic Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Infectious Disease POC Diagnostic Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Infectious Disease POC Diagnostic Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Infectious Disease POC Diagnostic Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Infectious Disease POC Diagnostic
Figure 2. Infectious Disease POC Diagnostic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infectious Disease POC Diagnostic Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Infectious Disease POC Diagnostic Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Infectious Disease POC Diagnostic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Infectious Disease POC Diagnostic Sales Market Share by Country/Region (2024)
Figure 10. Infectious Disease POC Diagnostic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lateral Flow Immunoassay
Figure 12. Product Picture of Agglutination Test
Figure 13. Product Picture of Flow-Through Test
Figure 14. Product Picture of Molecular Diagnostics
Figure 15. Product Picture of Others
Figure 16. Global Infectious Disease POC Diagnostic Sales Market Share by Type in 2025
Figure 17. Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2020-2025)
Figure 18. Infectious Disease POC Diagnostic Consumed in Hospital Bedside
Figure 19. Global Infectious Disease POC Diagnostic Market: Hospital Bedside (2020-2025) & (K Units)
Figure 20. Infectious Disease POC Diagnostic Consumed in Urgent Care and Retail Clinics
Figure 21. Global Infectious Disease POC Diagnostic Market: Urgent Care and Retail Clinics (2020-2025) & (K Units)
Figure 22. Infectious Disease POC Diagnostic Consumed in Home and Self-Testing
Figure 23. Global Infectious Disease POC Diagnostic Market: Home and Self-Testing (2020-2025) & (K Units)
Figure 24. Infectious Disease POC Diagnostic Consumed in Others
Figure 25. Global Infectious Disease POC Diagnostic Market: Others (2020-2025) & (K Units)
Figure 26. Global Infectious Disease POC Diagnostic Sale Market Share by Application (2024)
Figure 27. Global Infectious Disease POC Diagnostic Revenue Market Share by Application in 2025
Figure 28. Infectious Disease POC Diagnostic Sales by Company in 2025 (K Units)
Figure 29. Global Infectious Disease POC Diagnostic Sales Market Share by Company in 2025
Figure 30. Infectious Disease POC Diagnostic Revenue by Company in 2025 ($ millions)
Figure 31. Global Infectious Disease POC Diagnostic Revenue Market Share by Company in 2025
Figure 32. Global Infectious Disease POC Diagnostic Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Infectious Disease POC Diagnostic Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Infectious Disease POC Diagnostic Sales 2020-2025 (K Units)
Figure 35. Americas Infectious Disease POC Diagnostic Revenue 2020-2025 ($ millions)
Figure 36. APAC Infectious Disease POC Diagnostic Sales 2020-2025 (K Units)
Figure 37. APAC Infectious Disease POC Diagnostic Revenue 2020-2025 ($ millions)
Figure 38. Europe Infectious Disease POC Diagnostic Sales 2020-2025 (K Units)
Figure 39. Europe Infectious Disease POC Diagnostic Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Infectious Disease POC Diagnostic Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Infectious Disease POC Diagnostic Revenue 2020-2025 ($ millions)
Figure 42. Americas Infectious Disease POC Diagnostic Sales Market Share by Country in 2025
Figure 43. Americas Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2025)
Figure 44. Americas Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Figure 45. Americas Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)
Figure 46. United States Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Infectious Disease POC Diagnostic Sales Market Share by Region in 2025
Figure 51. APAC Infectious Disease POC Diagnostic Revenue Market Share by Region (2020-2025)
Figure 52. APAC Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Figure 53. APAC Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)
Figure 54. China Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 58. India Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Infectious Disease POC Diagnostic Sales Market Share by Country in 2025
Figure 62. Europe Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2025)
Figure 63. Europe Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Figure 64. Europe Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)
Figure 65. Germany Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 66. France Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Infectious Disease POC Diagnostic Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)
Figure 73. Egypt Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Infectious Disease POC Diagnostic Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Infectious Disease POC Diagnostic in 2025
Figure 79. Manufacturing Process Analysis of Infectious Disease POC Diagnostic
Figure 80. Industry Chain Structure of Infectious Disease POC Diagnostic
Figure 81. Channels of Distribution
Figure 82. Global Infectious Disease POC Diagnostic Sales Market Forecast by Region (2026-2031)
Figure 83. Global Infectious Disease POC Diagnostic Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Infectious Disease POC Diagnostic Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Infectious Disease POC Diagnostic Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Infectious Disease POC Diagnostic Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Infectious Disease POC Diagnostic Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Hybrid Audiometer Market Growth 2024-2030
US$ 3,660.00
December 2024
112 pages
Global Root Canal Gutta Percha Injection Filling Machine Market Growth 2023-2029
US$ 3,660.00
March 2023
118 pages
Global Holter ECG Monitoring System Market Growth 2023-2029
US$ 3,660.00
March 2023
103 pages
Global Tube for Medical Device Market Growth 2023-2029
US$ 3,660.00
March 2023
126 pages
Global Gas Sampling Line Market Growth 2023-2029
US$ 3,660.00
March 2023
109 pages
